Arranon Add-on Improves Long-term Outcomes in Young Patients with T-cell Cancers, Trial Shows
News
A combination of Arranon (nelarabine) and standard chemotherapy led to the highest survival rates seen to date in children and young adults with T-cell acute lymphoblastic leukemia (T-ALL), a Phase ... Read more